AI assistant
CVS HEALTH Corp — Director's Dealing 2021
Jan 12, 2021
29875_dirs_2021-01-12_83718cf2-76cd-41d1-a1aa-376626a0f6ce.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-01-08
Reporting Person: Lotvin Alan (EVP and President-CVS Caremark)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-08 | Common Stock | M | 10100 | $54.19 | Acquired | 18468.6799 | Direct |
| 2021-01-08 | Common Stock | M | 15736 | $74.29 | Acquired | 34204.6799 | Direct |
| 2021-01-08 | Common Stock | S | 25836 | $75.00 | Disposed | 8368.6799 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-01-08 | Stock Option | $54.19 | M | 10100 | Disposed | 2029-04-01 | Common Stock (10100) | Direct |
| 2021-01-08 | Stock Option | $74.29 | M | 15736 | Disposed | 2021-04-01 | Common Stock (15736) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 456.848 | Indirect |
| Common Stock (restricted) | 10346 | Direct |
| Stock Unit | 28643.2685 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Phantom Stock Credits | $1.00 | Common Stock (556.6312) | 556.6312 | Direct | |
| Stock Option | $102.26 | 2022-04-01 | Common Stock (21386) | 21386 | Direct |
| Stock Option | $104.82 | 2023-04-01 | Common Stock (27395) | 27395 | Direct |
| Stock Option | $78.05 | 2024-04-03 | Common Stock (32911) | 32911 | Direct |
| Stock Option | $62.21 | 2025-04-01 | Common Stock (22541) | 22541 | Direct |
| Stock Option | $58.34 | 2030-04-01 | Common Stock (140797) | 140797 | Direct |
Footnotes
F1: All sales were effected pursuant to a Rule 10b5-1 Trading Plan.
F2: Option became exercisable in four equal annual installments, commencing 4/1/2020.
F3: Remaining options became exercisable in four equal annual installments beginning on 4/1/2015.
F4: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F5: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F6: Option became exercisable in four equal annual installments beginning on 4/1/2016.
F7: Option became exercisable in four equal annual installments beginning on 4/1/2017.
F8: Option became exercisable in four equal annual installments beginning on 4/3/2018.
F9: Option became exercisable in four equal annual installments, commencing 4/1/2019.
F10: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.